Up­dat­ed: DOJ opens crim­i­nal probe in­to Cas­sa­va over al­le­ga­tions of Alzheimer's drug da­ta ma­nip­u­la­tion — re­port

Months af­ter re­ports of al­le­ga­tions re­gard­ing Cas­sa­va Sci­ences’ lead drug can­di­date for Alzheimer’s emerged, the DOJ may now be rais­ing its head to in­ves­ti­gate the com­pa­ny.

A re­port from Reuters pub­lished this morn­ing said that two sources had con­firmed the US De­part­ment of Jus­tice opened an in­ves­ti­ga­tion in­to Cas­sa­va over al­le­ga­tions that the biotech had ma­nip­u­lat­ed search re­sults re­lat­ed to simu­fil­am, the com­pa­ny’s ex­per­i­men­tal Alzheimer’s drug.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER